Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B47799a16c3ce700d37066b5a0ea1f59d> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B47799a16c3ce700d37066b5a0ea1f59d NCIT_P378 "NCI" @default.
- B47799a16c3ce700d37066b5a0ea1f59d type Axiom @default.
- B47799a16c3ce700d37066b5a0ea1f59d annotatedProperty IAO_0000115 @default.
- B47799a16c3ce700d37066b5a0ea1f59d annotatedSource NCIT_C180413 @default.
- B47799a16c3ce700d37066b5a0ea1f59d annotatedTarget "An antibody-drug conjugate (ADC) composed of a monoclonal antibody directed against the tumor-associated antigen (TAA) Claudin18.2 (CLDN18.2; A2 isoform of claudin-18) conjugated via a cleavable linker, to the microtubule-disrupting cytotoxic agent monomethyl auristatin E (MMAE), with potential antineoplastic activity. Upon administration, anti-CLDN18.2 ADC CMG901 specifically targets and binds to CLDN18.2 expressed on tumor cells. Upon internalization and the release of MMAE, MMAE targets and binds to tubulin, and inhibits microtubule polymerization. This results in G2/M phase cell cycle arrest and apoptosis in CLDN18.2-expressing tumor cells. CLDN18.2, a tight junction protein and stomach-specific isoform of claudin-18, is expressed on a variety of tumor cells. Its expression in healthy tissues is strictly confined to short-lived differentiated epithelial cells of the gastric mucosa." @default.